A deep learning model named Sybil can predict future lung cancer risk from a single low-dose chest CT scan, as validated in a large Asian cohort.
Key Details
- 1The Sybil model was validated using data from over 21,000 individuals aged 50-80 who underwent LDCT screening between 2009 and 2021.
- 2Sybil demonstrated strong predictive performance for lung cancer diagnosis both at one and six years following the scan.
- 3The model was effective even for never-smokers, a group for whom conventional screening guidelines may not apply.
- 4The research was presented at the ATS 2025 International Conference.
- 5Continued prospective validation is planned to assess clinical use and prediction of lung cancer-specific mortality.
Why It Matters
This advancement could help tailor lung cancer screening strategies, especially benefiting populations (such as Asian never-smokers) not well-served by current guidelines. A validated AI risk tool from a single scan could make screening more efficient and personalized in routine radiological practice.
Source
EurekAlert
Related News
•EurekAlert
AI Pathology Tool SÉMIL Improves Stage II Bowel Cancer Risk Assessment
A La Trobe University-developed AI tool accurately predicts relapse risk in stage II bowel cancer using digital pathology images and descriptions.
•EurekAlert
AI-Guided Handheld Cardiac Ultrasound Reduces Referrals and Costs in Spain
AI-guided handheld cardiac ultrasound enables primary care physicians to detect heart failure, reducing specialist referrals and saving costs.
•EurekAlert
AI Tool Predicts Which Rectal Cancer Patients Benefit from Intensive Therapy
UCL researchers developed an AI that analyzes biopsy slides to identify rectal cancer patients who benefit from adding irinotecan to standard chemoradiotherapy.